Carisma Therapeutics, Inc.

Carisma Therapeutics, Inc.verified

CARM

Price:

$0.0061

Market Cap:

$255.25K

Carisma Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to pioneering chimeric antigen receptor (CAR) macrophage therapies specifically designed to target solid cancerous growths. Its therapeutic approaches are instrumental in modulating both the inherent and acquired functions of the immune system. The company's sophisticated platform draws upon breakthroughs in macrophage science, CAR design, and cell-based treatments to address various human ailments. Notably, Carisma Therapeutics maintains a key strategic alliance with Moderna Inc. Incorporated in 2016 and headquartered in Philadelphia, Pennsylvania, the organization was initially established as CARMA Therapeutics Inc.,...[Read more]

Industry

Biotechnology

IPO Date

2014-02-06

Stock Exchange

OTC

Ticker

CARM

The ROE as of June 2026 (TTM) for Carisma Therapeutics, Inc. (CARM) is -28.86%

According to Carisma Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -28.86%. This represents a change of -97.71% compared to the average of -1261.99% of the last 4 quarters.

Carisma Therapeutics, Inc. (CARM) Historical ROE (quarterly & annually)

How has CARM ROE performed in the past?

The mean historical ROE of Carisma Therapeutics, Inc. over the last ten years is 22.90%. The current -28.86% ROE has changed -226.04% with respect to the historical average. Over the past ten years (40 quarters), CARM's ROE was at its highest in in the June 2020 quarter at 1.00%. The ROE was at its lowest in in the September 2025 quarter at -5157.67%.

Quarterly (TTM)
Annual

Average

22.90%

Median

2.35%

Minimum

-327.45%

Maximum

402.62%

Carisma Therapeutics, Inc. (CARM) ROE by Quarter and Year

Discovering the peaks and valleys of Carisma Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 88.31%

Maximum Annual ROE = 402.62%

Minimum Annual Increase = -20021.08%

Minimum Annual ROE = -327.45%

Quarterly (TTM)
Annual
YearROEChange
2024216.69%-166.18%
2023-327.45%-940.02%
202238.98%-20021.08%
2021-0.20%-100.06%
2020307.24%-23.69%
2019402.62%-628.26%
2018-76.22%-52.65%
2017-160.97%-3392.31%
20164.89%-102.77%
2015-176.58%88.31%

Carisma Therapeutics, Inc. (CARM) Average ROE

How has CARM ROE performed in the past?

The current ROE of Carisma Therapeutics, Inc. (CARM) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-23.93%

5-year avg

47.05%

10-year avg

22.90%

Carisma Therapeutics, Inc. (CARM) ROE vs. Peers

How is CARM’s ROE compared to its peers?

Carisma Therapeutics, Inc.’s ROE is greater than Jasper Therapeutics, Inc. (-523.04%), greater than Onconetix, Inc. (-105.46%), greater than Enveric Biosciences, Inc. (-220.99%), greater than SciSparc Ltd. (-704.60%), greater than Silexion Therapeutics Ltd. (-516.87%), greater than Salarius Pharmaceuticals, Inc. (-395.42%), greater than Revelation Biosciences, Inc. (-107.66%), less than CDT Equity Inc. (2.59%), greater than Indaptus Therapeutics, Inc. (-1028.81%), less than Aspire Biopharma Holdings, Inc. (199.43%),

Build a custom stock screener for Carisma Therapeutics, Inc. (CARM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carisma Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carisma Therapeutics, Inc. (CARM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carisma Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Carisma Therapeutics, Inc.'s ROE?

How is the ROE calculated for Carisma Therapeutics, Inc. (CARM)?

What is the highest ROE for Carisma Therapeutics, Inc. (CARM)?

What is the 3-year average ROE for Carisma Therapeutics, Inc. (CARM)?

What is the 5-year average ROE for Carisma Therapeutics, Inc. (CARM)?

How does the current ROE for Carisma Therapeutics, Inc. (CARM) compare to its historical average?